Cas 940865-91-8,1,1-dimethylethyl-(3S)-3-{[4-nitro-3-(trifluoromethyl)phenyl]amino}-1-pyrrolidinecarboxylate

940865-91-8

Post Buying Request

Basic information

Product Name: 1,1-dimethylethyl-(3S)-3-{[4-nitro-3-(trifluoromethyl)phenyl]amino}-1-pyrrolidinecarboxylate
Synonyms: 1,1-dimethylethyl-(3S)-3-{[4-nitro-3-(trifluoromethyl)phenyl]amino}-1-pyrrolidinecarboxylate
CAS NO:940865-91-8
Molecular Formula:
Molecular Weight: 375.348
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1,1-dimethylethyl-(3S)-3-{[4-nitro-3-(trifluoromethyl)phenyl]amino}-1-pyrrolidinecarboxylate(CAS DataBase Reference)
NIST Chemistry Reference: 1,1-dimethylethyl-(3S)-3-{[4-nitro-3-(trifluoromethyl)phenyl]amino}-1-pyrrolidinecarboxylate(940865-91-8)
EPA Substance Registry System: 1,1-dimethylethyl-(3S)-3-{[4-nitro-3-(trifluoromethyl)phenyl]amino}-1-pyrrolidinecarboxylate(940865-91-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 940865-91-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

940865-91-8 Suppliers

Recommended suppliers

940865-91-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 940865-91-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,0,8,6 and 5 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 940865-91:
(8*9)+(7*4)+(6*0)+(5*8)+(4*6)+(3*5)+(2*9)+(1*1)=198
198 % 10 = 8
So 940865-91-8 is a valid CAS Registry Number.

940865-91-8Upstream product

940865-91-8Downstream Products

940865-91-8Relevant academic research and scientific papers

PYRROLIDINEANILINES

-

Page/Page column 166, (2010/11/27)

The present invention relates to a compotind represented by the following formula I or a pharmaceutically acceptable salt thereof; wherein R1, R2, and y are defined herein. The present invention further relates to compositions that include the compound of the present invention as well as a method of treating a patient from endometreosis or uterine fibroids.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 940865-91-8